Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | The Biotech Growth Trust PLC (Ordinary Share) | +22.29% |
NAV | The Biotech Growth Trust PLC (Ordinary Share) | +19.57% |
Morningstar's Benchmark | NASDAQ Biotechnology TR GBP | -- |
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Total Voting Rights
- The Biotech Growth Trust PLC - Transaction in Own Shares
- The Biotech Growth Trust PLC - Monthly Fact Sheet as at 31 May 2024
- The Biotech Growth Trust PLC - Publication of a circular and notice of general meeting
- The Biotech Growth Trust PLC - Annual Financial Report
- The Biotech Growth Trust Plc - Transaction in Own Shares
- The Biotech Growth Trust Plc - Net Asset Value(s)
- The Biotech Growth Trust Plc - Monthly Fact Sheet as at 30 April 2024
- The Biotech Growth Trust Plc - Compliance with Market Abuse Regulation
More ▼
Key statistics
On Wednesday, The Biotech Growth Trust PLC (BIOG:LSE) closed at 958.00, -8.59% below its 52-week high of 1,048.00, set on May 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 32.96m |
---|---|
Market cap | 323.03m GBP |
Total assets | 354.26m GBP |
Total expense ratio | 1.18% |
High | 998.00 |
Low | 958.00 |
Previous close | 958.00 |
Average volume | 75.25k |
---|---|
YTD Change | +7.16% |
Beta | 0.6001 |
Diluted NAV (est) | 1,032.58 |
Diluted NAV (last pub) | 1,045.38 |
Premium/Discount | -7.22% |
Net Gearing | +2.43% |
Data delayed at least 20 minutes, as of Jul 03 2024 16:35 BST.
More ▼